$TMDX News
Last published 1d ago
- 1d agoTMDXSTIFEL 2026 HEALTHCARE CONFERENCE - TRANSMEDICS GROUP INCEarnings Call TranscriptsOkay. Morning everyone. Tom Steffen with Stiefel Research. Really excited to have transmedics at the conference this year for the first time. Waleed, Fernando, thanks so much for joining. Thank you. I'm going to jump rig
- 6d agoTMDXTransMedics Group, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoTMDXTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR NewswireANDOVER, Mass., Oct. 30, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung,
- 1w agoTMDXTransMedics to Present at Upcoming Investor ConferencesPR NewswireANDOVER, Mass., Oct. 29, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung,
- 2w agoTMDXTransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026PR NewswireANDOVER, Mass., Oct. 22, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung,
- 1mo agoTMDXBAIRD 2026 GLOBAL HEALTHCARE CONFERENCE - TRANSMEDICS GROUP INCEarnings Call TranscriptsThanks everyone for joining us. I'm Dave Rescott, Senior MedTech Analyst here at Baird. Happy to have Waleed with us from Transmedics, President and CEO of the company. I think he's going to walk through maybe 10 minutes
- 1mo agoTMDXBAIRD 2026 GLOBAL HEALTHCARE CONFERENCE - TRANSMEDICS GROUP INCEarnings Call TranscriptsThanks everyone for joining us. I'm Dave Rescott, Senior MedTech Analyst here at Baird. Happy to have Waleed with us from Transmedics, President and CEO of the company. I think he's going to walk through maybe 10 minutes
- 1mo agoTMDXTransMedics at Morgan Stanley 24th Annual Global Healthcare Conference - TRANSMEDICS GROUP INCEarnings Call TranscriptsThank you, everybody, for coming in today, and I'm going to read the important disclaimer, which you can find on the Morgan Stanley website. And with that, I'd like to welcome Waleed Hassanein, CEO and founder of Transme
- 1mo agoTMDXMorgan Stanley 24th Annual Global Healthcare Conference - TRANSMEDICS GROUP INCEarnings Call TranscriptsThank you, everybody, for coming in today, and I'm going to read the important disclaimer, which you can find on the Morgan Stanley website. And with that, I'd like to welcome Waleed Hassanein, CEO and founder of Transme
- 2mo agoTMDXTransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial OutlookPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today...
- 2mo agoTMDXTransMedics to Present at Upcoming September Investor ConferencesPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 2mo agoTMDXDid TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireShareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket
- 3mo agoTMDXCG 46TH ANNUAL GROWTH CONFERENCE - TRANSMEDICS GROUP INCEarnings Call TranscriptsGood afternoon. My name is Bill Plobonik. I'm a senior analyst here on the MedTech team with Canaccord Genuity. Welcome to our 46th annual Global Growth Conference. With us up next, we have Transmedics. And the format th
- 3mo agoTMDXCG 46TH ANNUAL GROWTH CONFERENCE - TRANSMEDICS GROUP INCEarnings Call TranscriptsGood afternoon. My name is Bill Plobonik. I'm a senior analyst here on the MedTech team with Canaccord Genuity. Welcome to our 46th annual Global Growth Conference. With us up next, we have Transmedics. And the format th
- 3mo agoTMDXCG 46TH ANNUAL GROWTH CONFERENCE - TRANSMEDICS GROUP INCEarnings Call TranscriptsGood afternoon. My name is Bill Plobonik. I'm a senior analyst here on the MedTech team with Canaccord Genuity. Welcome to our 46th annual Global Growth Conference. With us up next, we have Transmedics. And the format th
- 3mo agoTMDXTransMedics Reports Second Quarter 2026 Financial ResultsPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 3mo agoTMDXTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 3mo agoTMDXTransMedics to Present at the Canaccord Genuity 46th Annual Growth ConferencePR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 3mo agoTMDXTransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 4mo agoTMDXTransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbHPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 5mo agoTMDXWILLIAM BLAIR 46TH ANNUAL GROWTH STOCK CONFERENCE - TRANSMEDICS GROUP INCEarnings Call TranscriptsThank you all for coming to the Transmedics presentation. For those of you whom I've not yet met, my name is Ryan Daniels. I'm the group head of the Healthcare Equity Research Team, so very happy to welcome you all to to
- 5mo agoTMDXTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 5mo agoTMDXTransMedics to Present at the William Blair 46th Annual Growth Stock ConferencePR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 6mo agoTMDXTransMedics Reports First Quarter 2026 Financial ResultsPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 6mo agoTMDXTransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbHPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 6mo agoSENSTMDXTXGThe Quiet Rule Change Tilting $10B Toward Medtech's Most Validated PlatformsPR NewswireEquity-Insider.com News Commentary – Here's the quiet shift in medtech right now: the global medical imaging market is on track to grow from $41.64...
- 6mo agoTMDXTransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual MeetingPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 6mo agoTMDXTransMedics to Report First Quarter 2026 Financial Results on May 5, 2026PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 8mo agoTMDXTransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial ResultsPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 8mo agoTMDXTransMedics Reports Fourth Quarter and Full Year 2025 Financial ResultsPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 8mo agoTMDXTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 8mo agoTMDXTransMedics to Present at Upcoming March Investor ConferencesPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 9mo agoTMDXTransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 9mo agoTMDXTransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE TrialPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 10mo agoTMDXTransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, MassachusettsPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a global leader in organ transplant technologies and services, today announced the signing of ...
- 10mo agoTMDXTransMedics to Participate in the 44th Annual J.P. Morgan Healthcare ConferencePR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 10mo agoTMDXTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 11mo agoTMDXTransMedics to Participate in the Piper Sandler 37th Annual Healthcare ConferencePR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics Q3 2025 Earnings Conference Call - TRANSMEDICS GROUP INCEarnings Call TranscriptsGood afternoon and welcome to the Transmedics third quarter 2025 earnings conference call. At this time, all participants are in the listen-only mode. We will be facilitating a question-answer session towards the end of
- 1y agoTMDXTransMedics Reports Third Quarter 2025 Financial ResultsPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in ItalyPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in ItalyPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics Group, Inc. (TMDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
- 1y agoTMDXTransMedics to Present at Upcoming September Investor ConferencesPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart TrialPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
- 1y agoTMDXTransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoTMDXTransMedics Reports Second Quarter 2025 Financial ResultsPR NewswireTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...